Vetoquinol SA (0O1O.L)

EUR 76.5

(0.0%)

Net Income Summary of Vetoquinol SA

  • Vetoquinol SA's latest annual net income in 2023 was 55.56 Million EUR , up 15.76% from previous year.
  • Vetoquinol SA's latest quarterly net income in 2024 Q2 was 23.8 Million EUR , down 0.0% from previous quarter.
  • Vetoquinol SA reported an annual net income of 47.99 Million EUR in 2022, down -23.65% from previous year.
  • Vetoquinol SA reported an annual net income of 62.86 Million EUR in 2021, up 227.04% from previous year.
  • Vetoquinol SA reported a quarterly net income of 32.22 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Vetoquinol SA reported a quarterly net income of 23.33 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Vetoquinol SA (2023 - 2005)

Historical Annual Net Income of Vetoquinol SA (2023 - 2005)

Year Net Income Net Income Growth
2023 55.56 Million EUR 15.76%
2022 47.99 Million EUR -23.65%
2021 62.86 Million EUR 227.04%
2020 19.22 Million EUR -32.77%
2019 28.58 Million EUR -21.15%
2018 36.25 Million EUR 4.1%
2017 34.83 Million EUR 25.17%
2016 27.82 Million EUR 15.2%
2015 24.15 Million EUR -6.25%
2014 25.76 Million EUR 9.27%
2013 23.58 Million EUR 4.48%
2012 22.56 Million EUR -0.56%
2011 22.69 Million EUR 1.98%
2010 22.25 Million EUR 22.23%
2009 18.2 Million EUR -1.92%
2008 18.56 Million EUR -0.42%
2007 18.64 Million EUR 17.81%
2006 15.82 Million EUR 27.2%
2005 12.44 Million EUR 0.0%

Peer Net Income Comparison of Vetoquinol SA

Name Net Income Net Income Difference
Boiron SA 35.82 Million EUR -55.079%
Laboratorios Farmaceuticos Rovi, S.A. 170.33 Million EUR 67.382%
Valneva SE -101.42 Million EUR 154.777%
AB Science S.A. -10.04 Million EUR 652.946%
Nanobiotix S.A. -39.7 Million EUR 239.95%
PHAXIAM Therapeutics S.A. -23.48 Million EUR 336.546%
Vivoryon Therapeutics N.V. -28.34 Million EUR 296.034%
BioSenic S.A. -28.77 Million EUR 293.064%
ABIVAX Société Anonyme -147.74 Million EUR 137.607%
Formycon AG 75.79 Million EUR 26.697%